{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-025720","form_type":"8-K","ticker":"IVF","cik":"0001417926","company_name":"INVO Fertility, Inc.","filed_at":"2023-07-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.861918+00:00","generated_at":"2026-06-13T00:13:56.212923+00:00","sec_items":["5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"INVO Bioscience 1-for-20 reverse stock split effective July 28; Nasdaq panel grants continued listing until Sept 29","bullets":["Reverse split every 20 shares into 1; effective 12:01 a.m. ET July 28, 2023; trading symbol unchanged (INVO).","Post-split shares outstanding ~842,017; authorized shares reduced to 6,250,000; fractional shares rounded up.","Nasdaq Hearings Panel granted continued listing subject to compliance with $1.00 bid price and $2.5M equity by Sept 29, 2023.","Reverse split intended to regain Nasdaq minimum bid price compliance; no assurance of success.","Company previously non-compliant with bid price and equity requirements; July 6 hearing discussed."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-025720","json":"https://secwatch.observer/filing/0001493152-23-025720.json","markdown":"https://secwatch.observer/filing/0001493152-23-025720.md","text":"https://secwatch.observer/filing/0001493152-23-025720.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1417926/000149315223025720/0001493152-23-025720-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1417926/000149315223025720/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T00:13:56.212923+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"bb69d31943442b17c4d19d5e8db943337b7bf7e7","claim":"INVO Fertility, Inc.: Effected a 1-for-20 reverse stock split of common stock, adjusting authorized shares to 6,250,000 (effective 2023-07-28).","evidence_excerpt":"On July 26, 2023, INVO Bioscience, Inc. (the “Company”) filed a Certificate of Change (the “Certificate of Change”) with the Secretary of State of the State of Nevada to effectuate a 1-for-20 reverse stock split (the “Reverse Stock Split”) of the Company’s issued and outstanding and authorized shares of common stock, par value $0.0001 per share (“Common Stock”). The Reverse Stock Split will become effective at 12:01 a.m., Eastern Time, on Friday, July 28, 2023","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1417926/000149315223025720/0001493152-23-025720-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-07-28"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}